China Universal Asset Management Co., Ltd. - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 32 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
China Universal Asset Management Co., Ltd. ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2022$02880.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Newtyn Management, LLC 1,800,000$1,350,1800.33%
Deuterium Capital Management, LLC 11,000$8,8000.02%
Duquesne Family Office 100,000$800.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 112,900$84,6860.00%
RAYMOND JAMES & ASSOCIATES 14,000$11,2000.00%
TWO SIGMA INVESTMENTS, LP 10,876$8,7010.00%
BANK OF AMERICA CORP /DE/ 90,774$72,6190.00%
WELLS FARGO & COMPANY/MN 132$1060.00%
NORTHERN TRUST CORP 26,049$20,8390.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders